Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Rocketman who wrote (5793)	10/23/1998 12:06:00 AM
From: Andrew H	Read Replies (1) \| Respond to of 9719

>>As I've always contended, when the markets in general suck, biotechs will shine. << I don't know about that, Rman. When the DOW was at 7400, biotechs were bottoming hard. I think bios will need a strong market to do well over the next couple of years at least, especially those without earnings. Yeah the Beatle Eater is truly the unsung hero of the thread--such consistency of quality work and dedication is a rare quality. No wood fireplace, only one of those converted gas fireplaces here (at least there are no ashes) but we do have a nice hot tub/jacuzzi which will be a big help through the winter...

To: Rocketman who wrote (5793)	10/23/1998 11:10:00 AM
From: rkrw	Read Replies (1) \| Respond to of 9719

A little devil's advocate on AMLN. Cash is $25M. 35M shares. So 71 cents a share in cash, well above current levels. The problem is on the liability side. $15.3M in current liabilities. $43.4M in "other" liabilities. What are the "other" liabilities? Book value is a negative $24M. Just want to make sure you aren't playing with a company that is essentially bankrupt. Since you aren't planning to hold for too long, I suppose the fact that it could delist in less than a month is not a concern.